Gramercy Funds Management’s Bausch Health BHC Stock Holding History

Gramercy Funds Management’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-37,500	Closed	-$686K	–	16
2020 Q2	$686K	Hold	37,500	–	–	0.1%	17
2020 Q1	$581K	Hold	37,500	–	–	0.12%	16
2019 Q4	$1.12M	Hold	37,500	–	–	0.84%	15
2019 Q3	$819K	Hold	37,500	–	–	0.55%	15
2019 Q2	$946K	Hold	37,500	–	–	0.48%	17
2019 Q1	$926K	Hold	37,500	–	–	0.25%	19
2018 Q4	$693K	Hold	37,500	–	–	0.13%	18
2018 Q3	$963K	Hold	37,500	–	–	0.19%	15
2018 Q2	$872K	Hold	37,500	–	–	0.17%	18
2018 Q1	$597K	Buy	37,500 +11,100	+42%	+$207K	0.12%	7
2017 Q4	$549K	Buy	26,400 +1,100	+4%	+$17.4K	0.09%	18
2017 Q3	$363K	Buy	25,300 +13,500	+114%	+$204K	0.07%	23
2017 Q2	$204K	Sell	11,800 -70,700	-86%	-$848K	0.04%	25
2017 Q1	$910K	Buy	82,500 +32,500	+65%	+$447K	1.1%	19
2016 Q4	$726K	Buy	50,000 +25,000	+100%	+$459K	0.37%	36
2016 Q3	$614K	Buy	+25,000	New	+$647K	0.21%	46

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

PIP

Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gramercy Funds Management's BHC Position: Q3 2020 in Review

Gramercy Funds Management sold out of Bausch Health (BHC) in Q3 2020, closing a stake of 37,500 shares — an estimated $686K sold.

Gramercy Funds Management first reported a position in BHC in Q3 2016 and held it in 16 quarters. The position peaked at $1.12M in Q4 2019. 324 funds tracked by Wall St. Rank hold BHC as of Q3 2020.

Gramercy Funds Management reported no remaining Bausch Health position as of Q3 2020 after selling out during the quarter.
Gramercy Funds Management sold 37,500 Bausch Health shares in Q3 2020, an estimated $686K.
Gramercy Funds Management first reported a position in Bausch Health in Q3 2016 and held it in 16 quarters.
Gramercy Funds Management's Bausch Health position peaked at $1.12M in Q4 2019.
324 funds tracked by Wall St. Rank held Bausch Health as of Q3 2020.

Based on Gramercy Funds Management's 13F filing for Q3 2020, filed 16 Nov 2020.